Polymerase chain response (PCR) using deoxyribonucleic acid (DNA) extracted from dried blood spots (DBS) supplies a quick, cheap, and handy methodology for large-scale epidemiological research. This research in contrast the performance of PCR between DNA extracted from DBS and DNA obtained from whole blood for detecting malarial parasites. Primary research assessing the diagnostic performance of PCR using DNA extracted from DBS and whole blood for detecting malarial parasites have been obtained from the ISI Web of Science, Scopus, and PubMed databases. Odds ratios (ORs) and 95% confidence intervals (CIs) have been plotted in forest plots using Review Manager model 5.3. Statistical evaluation was carried out through random-effects meta-analysis.
Data heterogeneity was assessed using the I2 statistic. Of the 904 research retrieved from the databases, seven have been included on this research. The pooled meta-analysis demonstrated no vital distinction within the comparative performance of PCR for detecting malaria parasites between DNA extracted from DBS and that extracted from whole blood (OR 0.85; 95% CI 0.62-1.16; I2 = 78%). However, subgroup evaluation demonstrated that PCR using DNA extracted from DBS was much less correct in detecting Plasmodium vivax than that using DNA extracted from whole blood (OR = 0.85; 95% CI 0.77-0.94).
In conclusion, a vital distinction in detecting P. vivax was noticed between PCR using DNA extracted from DBS and that using DNA extracted from whole blood. Therefore, P. vivax in endemic areas ought to be recognized and detected with care with PCR using DNA obtained from DBS which doubtlessly results in a unfavourable outcome. Further research are required to research the performance of PCR using DBS for detecting P. vivax and different malarial parasites to supply knowledge in analysis and routine surveillance of malaria, particularly with renewed efforts in the direction of the eradication of the illness.
It is commonly troublesome to tell apart morphologically between intently associated species of fleas (Siphonaptera). Morphological identification of fleas usually requires microscopic examination of inner buildings in specimens cleared using caustic options. This course of degrades DNA and/or inhibits DNA extraction from specimens, which limits molecular-based research on particular person fleas and their microbiomes. Our goal was to tell apart between Oropsylla rupestris (Jordan), Oropsylla tuberculata (Baker), Oropsylla bruneri (Baker), and Oropsylla labis (Jordan & Rothschild) (Ceratophyllidae) using PCR-based single strand conformation polymorphism (SSCP) analyses and DNA sequencing. A 446 bp area of the nuclear 28S ribosomal RNA (rRNA) gene was used because the genetic marker.
Ionizing radiation, genotoxic stress, and mitochondrial DNA copy-number variation in Caenorhabditis elegans: droplet digital PCR evaluation
Mitochondria are weak to the results of ionizing radiation; harm to mitochondrial DNA (mtDNA) could also be extra intensive and persistent than harm to nuclear DNA (nDNA). Variation in mtDNA copy quantity has been proposed as a marker for mitochondrial dysfunction in response to ionizing radiation. We have developed a exact and delicate duplex droplet digital PCR (ddPCR) methodology for quantitation of the mtDNA/nDNA ratio within the mannequin organism Caenorhabditis elegans. The impact on this ratio was investigated over a big selection of doses (0.03-72 Gy) of power gamma irradiation.
Five mitochondrial targets and two nuclear reference genes have been amplified pairwise in duplex PCR format (one mitochondrial and one nuclear goal per PCR) by each ddPCR and quantitative PCR (qPCR). The outcomes confirmed that ddPCR however not qPCR enabled detection of a vital enhance in mtDNA copy quantity (1.6 ± 0.1-fold) for nematodes uncovered to excessive doses (≥24 Gy). Thus, ddPCR offered larger precision and larger sensitivity than qPCR for detection of mtDNA copy quantity variation. The variation adopted a Hill-type dose response with threshold 10.3 ± 1 Gy. This strongly means that power genotoxic stress impacts mtDNA replication. The duplex ddPCR methodology is a novel, high-precision, delicate software for willpower of mitochondrial DNA copy quantity variation and operate in C. elegans.
The outcomes obtained for 36 reference specimens (i.e., fleas that have been morphologically recognized to species) revealed no intraspecific variation in DNA sequence, whereas the DNA sequences of the 4 species of Oropsylla differed from each other at two to 6 nucleotide positions. Each flea species additionally had a distinctive SSCP banding sample. SSCP analyses have been then used to establish one other 84 fleas that had not been recognized morphologically. DNA sequencing knowledge confirmed the species id of fleas subjected to SSCP. This demonstrates that PCR-SSCP mixed with DNA sequencing of the 28S rRNA gene is a very efficient method for the delineation of 4 intently associated species of flea.
The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of sufferers with colorectal most cancers: A protocol for systematic assessment and meta-evaluation
Cetuximab and panitumumab have been used clinically to deal with metastatic colorectal most cancers for greater than 15 years. Before the remedy is given, it’s required to find out the KRAS mutation standing since it might result in drug resistance. Tumor tissue pattern is historically used for most cancers genotyping. In current years, liquid biopsy pattern has been intensively investigated as a surrogate for tumor tissue pattern resulting from its non-invasiveness and higher presentation of tumor heterogeneity.
PE anti-human CD226 (DNAM-1) |
E16FHP226-025 |
EnoGene |
25 tests |
EUR 433.33 |
Description: Available in various conjugation types. |
PE anti-human CD226 (DNAM-1) |
E16FHP226-100 |
EnoGene |
100 tests |
EUR 931.67 |
Description: Available in various conjugation types. |
APC anti-human CD226 (DNAM-1) |
E16FHA226-025 |
EnoGene |
25 tests |
EUR 455 |
Description: Available in various conjugation types. |
APC anti-human CD226 (DNAM-1) |
E16FHA226-100 |
EnoGene |
100 tests |
EUR 975 |
Description: Available in various conjugation types. |
FITC anti-human CD226 (DNAM-1) |
E16FHF226-025 |
EnoGene |
25 tests |
EUR 368.33 |
Description: Available in various conjugation types. |
FITC anti-human CD226 (DNAM-1) |
E16FHF226-100 |
EnoGene |
100 tests |
EUR 845 |
Description: Available in various conjugation types. |
Purified anti-human CD226 (DNAM-1) |
E16FHU226-100U |
EnoGene |
100 μg |
EUR 455 |
Description: Available in various conjugation types. |
Anti-Human CD226/DNAM-1 Antibody (SAA0074) |
MBS1564467-01mg |
MyBiosource |
0.1mg |
EUR 405 |
Anti-Human CD226/DNAM-1 Antibody (SAA0074) |
MBS1564467-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1520 |
Mouse Monoclonal anti-human DNAM-1 (CD226) |
hAP-0248 |
Angio Proteomie |
100ug |
EUR 250 |
Sheep Polyclonal anti-Human DNAM-1 (CD226) |
hAP-5851 |
Angio Proteomie |
50ug |
EUR 400 |
Recombinant Human DNAM-1/CD226 Protein |
RP00324 |
Abclonal |
10μg |
EUR 123.99 |
Recombinant Human DNAM-1/CD226 Protein |
RP00958 |
Abclonal |
10μg |
EUR 123.99 |
Recombinant Human DNAM-1/CD226 Protein |
RP02028 |
Abclonal |
100μg |
EUR 233.81 |
Recombinant Human DNAM-1/CD226 Protein |
RP02251 |
Abclonal |
10μg |
EUR 209.01 |
PE anti-mouse CD226 (DNAM-1) |
E16FMP226-025U |
EnoGene |
25 μg |
EUR 433.33 |
Description: Available in various conjugation types. |
PE anti-mouse CD226 (DNAM-1) |
E16FMP226-100U |
EnoGene |
100 μg |
EUR 1148.33 |
Description: Available in various conjugation types. |
DNAM-1 Antibody |
B0843-100ul |
Assay Biotech |
100μl |
EUR 217 |
Description: DNAM-1 Rabbit Polyclonal Antibody |
DNAM-1 Antibody |
B0843-50ul |
Assay Biotech |
50μl |
EUR 143.5 |
Description: DNAM-1 Rabbit Polyclonal Antibody |
DNAM-1 Antibody |
C30497-100ul |
Assay Biotech |
100μl |
EUR 217 |
Description: DNAM-1 Rabbit Polyclonal Antibody |
DNAM-1 Antibody |
C30497-50ul |
Assay Biotech |
50μl |
EUR 143.5 |
Description: DNAM-1 Rabbit Polyclonal Antibody |
APC anti-mouse CD226 (DNAM-1) |
E16FMA226-025U |
EnoGene |
25 μg |
EUR 498.33 |
Description: Available in various conjugation types. |
APC anti-mouse CD226 (DNAM-1) |
E16FMA226-100U |
EnoGene |
100 μg |
EUR 1256.67 |
Description: Available in various conjugation types. |
FITC anti-mouse CD226 (DNAM-1) |
E16FMF226-050U |
EnoGene |
50 μg |
EUR 541.67 |
Description: Available in various conjugation types. |
Human DNAM-1 / CD226 Protein, Fc Tag |
DN1-H5257 |
ACROBIOSYSTEMS |
1mg |
EUR 267.5 |
|
Description: Human DNAM-1, Fc Tag (DN1-H5257) is expressed from human 293 cells (HEK293). It contains AA Glu 19 - Asn 247 (Accession # NP_006557). |
PE Rabbit anti-Human DNAM-1/CD226 mAb |
A23591 |
Abclonal |
25μg |
EUR 1557.4 |
|
Description: Recombinant fusion protein containing a sequence corresponding to amino acids 250-473 of human MEF2A+MEF2C (Q06413). |
Human DNAM-1 / CD226 Protein, His Tag |
DN1-H52H6 |
ACROBIOSYSTEMS |
1mg |
EUR 267.5 |
|
Description: Human DNAM-1, His Tag (DN1-H52H6) is expressed from human 293 cells (HEK293). It contains AA Glu 19 - Asn 247 (Accession # NP_006557). |
Human DNAM-1 Protein, mFc-His Tag |
E33P100050 |
EnoGene |
10 μg |
EUR 225 |
Human DNAM-1 Protein, mFc-His Tag |
MBS8575099-001mg |
MyBiosource |
0.01mg |
EUR 305 |
Human DNAM-1 Protein, mFc-His Tag |
MBS8575099-5x001mg |
MyBiosource |
5x0.01mg |
EUR 1220 |
Mouse Monoclonal anti-Human CD226 (DNAM-1) Antibody |
xAP-0182 |
Angio Proteomie |
100ug |
EUR 280 |
Mouse Monoclonal anti-Human CD226 (DNAM-1) Antibody |
xAP-0183 |
Angio Proteomie |
100ug |
EUR 280 |
Active Recombinant Human DNAM-1/CD226 Protein |
RP00283 |
Abclonal |
10 μg |
EUR 78 |
|
Human DNAM-1/CD226 ELISA Kit PicoKine® |
EK2161 |
BosterBio |
96 wells/kit, with removable strips. |
EUR 499 |
Description: Human DNAM-1/CD226 ELISA Kit PicoKine® (96 Tests). Quantitate Human CD226 in cell culture supernatants, serum and plasma (heparin, EDTA). Sensitivity: 5 pg/ml. |
Recombinant Human CD226 Antigen/DNAM-1/CD226 (C-Fc) |
AP76445 |
SAB |
1mg |
EUR 1879 |
|
Recombinant Human CD226 Antigen/DNAM-1/CD226 (C-Fc) |
CS90-10ug |
Novoprotein |
10ug |
EUR 151.2 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human CD226 Antigen/DNAM-1/CD226 (C-Fc) |
CS90-1mg |
Novoprotein |
1mg |
EUR 1581.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human CD226 Antigen/DNAM-1/CD226 (C-Fc) |
CS90-500ug |
Novoprotein |
500ug |
EUR 1155.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human CD226 Antigen/DNAM-1/CD226 (C-Fc) |
CS90-50ug |
Novoprotein |
50ug |
EUR 333.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
NE Purified anti-mouse CD226 (DNAM-1) |
E16FMY226-500U |
EnoGene |
500 μg |
EUR 1625 |
Description: Available in various conjugation types. |
Rabbit anti Mouse DNAM-1 Monoclonal Antibody |
MBS2544521-006mL |
MyBiosource |
0.06mL |
EUR 335 |
Rabbit anti Mouse DNAM-1 Monoclonal Antibody |
MBS2544521-012mL |
MyBiosource |
0.12mL |
EUR 520 |
Rabbit anti Mouse DNAM-1 Monoclonal Antibody |
MBS2544521-02mL |
MyBiosource |
0.2mL |
EUR 800 |
CD226 / DNAM-1 Antibody |
20-abx119383 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 10 ug
- 200 ug
- 300 µg
|
|
CD226/DNAM-1 Antibody |
E11-184778 |
EnoGene |
100ug/100ul |
EUR 225 |
Description: Available in various conjugation types. |
CD226/DNAM-1 Antibody |
E18-0087-1 |
EnoGene |
50μg/50μl |
EUR 145 |
Description: Available in various conjugation types. |
CD226/DNAM-1 Antibody |
E18-0087-2 |
EnoGene |
100μg/100μl |
EUR 225 |
Description: Available in various conjugation types. |
CD226/DNAM-1 Antibody |
AF0087 |
Affbiotech |
200ul |
EUR 420 |
CD226/DNAM-1 Antibody |
AF4778 |
Affbiotech |
200ul |
EUR 540 |
Cd226 Antibody / Dnam-1 |
RQ6373 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
|
Description: DNAM 1, also known as CD226, is a receptor expressed by peripheral blood T lymphocytes that is involved in intercellular adhesion, lymphocyte signaling, cytotoxicity and lymphokine secretion mediated by cytotoxic T lymphocytes. DNAM 1 is broadly expressed on T cells, NK cells, platelets, monocytes and a subset of B cells. DNAM-1 is also expressed by a subset of CD3 positive thymocytes. This antibody is reported to inhibit T- and NK cell mediated cytotoxicity against tumour cell targets and to block TNF alpha and IFN gamma secretion by alloantigen-specific T-cells. |
CD226 Antibody / DNAM-1 |
RQ6841 |
NSJ Bioreagents |
100ug |
EUR 356.15 |
|
Description: DNAM 1, also known as CD226, is a receptor expressed by peripheral blood T lymphocytes that is involved in intercellular adhesion, lymphocyte signaling, cytotoxicity and lymphokine secretion mediated by cytotoxic T lymphocytes. DNAM 1 is broadly expressed on T cells, NK cells, platelets, monocytes and a subset of B cells. DNAM-1 is also expressed by a subset of CD3 positive thymocytes. This antibody is reported to inhibit T- and NK cell mediated cytotoxicity against tumour cell targets and to block TNF alpha and IFN gamma secretion by alloantigen-specific T-cells. |
CD226/DNAM-1 Antibody |
MBS8510593-005mg |
MyBiosource |
0.05mg |
EUR 235 |
CD226/DNAM-1 Antibody |
MBS8510593-01mg |
MyBiosource |
0.1mg |
EUR 305 |
CD226/DNAM-1 Antibody |
MBS8510593-01mLAF405M |
MyBiosource |
0.1mL(AF405M) |
EUR 465 |
CD226/DNAM-1 Antibody |
MBS8510593-01mLAF546 |
MyBiosource |
0.1mL(AF546) |
EUR 465 |
CD226/DNAM-1 Antibody |
MBS8510593-01mLAF750 |
MyBiosource |
0.1mL(AF750) |
EUR 465 |
CD226/DNAM-1 Antibody |
MBS8529317-01mg |
MyBiosource |
0.1mg |
EUR 305 |
CD226/DNAM-1 Antibody |
MBS8529317-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 465 |
CD226/DNAM-1 Antibody |
MBS8529317-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 465 |
CD226/DNAM-1 Antibody |
MBS8529317-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 465 |
CD226/DNAM-1 Antibody |
MBS8529317-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 465 |
CD226/DNAM-1 Antibody |
MBS9613485-005mL |
MyBiosource |
0.05mL |
EUR 245 |
CD226/DNAM-1 Antibody |
MBS9613485-01mL |
MyBiosource |
0.1mL |
EUR 305 |
CD226/DNAM-1 Antibody |
MBS9613485-02mL |
MyBiosource |
0.2mL |
EUR 365 |
CD226/DNAM-1 Antibody |
MBS9613485-5x02mL |
MyBiosource |
5x0.2mL |
EUR 1495 |
CD226/DNAM-1 Antibody |
MBS9503809-005mL |
MyBiosource |
0.05mL |
EUR 285 |
CD226/DNAM-1 Antibody |
MBS9503809-01mL |
MyBiosource |
0.1mL |
EUR 385 |
CD226/DNAM-1 Antibody |
MBS9503809-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1590 |
CD226/DNAM-1 Antibody |
MBS9509278-005mL |
MyBiosource |
0.05mL |
EUR 285 |
CD226/DNAM-1 Antibody |
MBS9509278-01mL |
MyBiosource |
0.1mL |
EUR 385 |
CD226/DNAM-1 Antibody |
MBS9509278-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1590 |
CD226/DNAM-1 Antibody |
MBS9600037-01mL |
MyBiosource |
0.1mL |
EUR 260 |
CD226/DNAM-1 Antibody |
MBS9600037-02mL |
MyBiosource |
0.2mL |
EUR 305 |
CD226/DNAM-1 Antibody |
MBS9600037-5x02mL |
MyBiosource |
5x0.2mL |
EUR 1220 |
CD226/DNAM-1 Antibody |
AF0087-100ul |
Affinity Biosciences |
100ul |
EUR 168 |
Description: WB,IF/ICC,ELISA(peptide) |
CD226/DNAM-1 Antibody |
AF0087-200ul |
Affinity Biosciences |
200ul |
EUR 210 |
Description: WB,IF/ICC,ELISA(peptide) |
Recombinant Human DNAM-1 Protein, Avi & His Tag |
E40KMP1218 |
EnoGene |
20ug |
EUR 495 |
Recombinant Human DNAM-1 Protein, Avi & His Tag |
E40KMP1892 |
EnoGene |
20ug |
EUR 495 |
Recombinant Human CD226 Antigen/DNAM-1/CD226 (C-6His) |
AP76444 |
SAB |
1mg |
EUR 1879 |
|
Recombinant Human CD226 Antigen/DNAM-1/CD226 (C-6His) |
CS89-10ug |
Novoprotein |
10ug |
EUR 151.2 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human CD226 Antigen/DNAM-1/CD226 (C-6His) |
CS89-1mg |
Novoprotein |
1mg |
EUR 1581.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human CD226 Antigen/DNAM-1/CD226 (C-6His) |
CS89-500ug |
Novoprotein |
500ug |
EUR 1155.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human CD226 Antigen/DNAM-1/CD226 (C-6His) |
CS89-50ug |
Novoprotein |
50ug |
EUR 333.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
DNAM-1 Polyclonal Antibody |
ABP53533-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
Description: A polyclonal antibody for detection of DNAM-1 from Human, Mouse, Monkey. This DNAM-1 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human DNAM-1 around the non-phosphorylation site of S329 |
DNAM-1 Polyclonal Antibody |
ABP53533-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
Description: A polyclonal antibody for detection of DNAM-1 from Human, Mouse, Monkey. This DNAM-1 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human DNAM-1 around the non-phosphorylation site of S329 |
DNAM-1 Polyclonal Antibody |
ABP53533-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
Description: A polyclonal antibody for detection of DNAM-1 from Human, Mouse, Monkey. This DNAM-1 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human DNAM-1 around the non-phosphorylation site of S329 |
DNAM-1 Polyclonal Antibody |
ABP53133-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
Description: A polyclonal antibody for detection of DNAM-1 from Human. This DNAM-1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human DNAM-1 |
DNAM-1 Polyclonal Antibody |
ABP53133-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
Description: A polyclonal antibody for detection of DNAM-1 from Human. This DNAM-1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human DNAM-1 |
DNAM-1 Polyclonal Antibody |
ABP53133-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
Description: A polyclonal antibody for detection of DNAM-1 from Human. This DNAM-1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human DNAM-1 |
DNAM-1 Polyclonal Antibody |
41787-100ul |
SAB |
100ul |
EUR 302.4 |
DNAM-1 Polyclonal Antibody |
41787-50ul |
SAB |
50ul |
EUR 224.4 |
DNAM-1 Polyclonal Antibody |
40846-100ul |
SAB |
100ul |
EUR 302.4 |
DNAM-1 Polyclonal Antibody |
40846-50ul |
SAB |
50ul |
EUR 224.4 |
DNAM-1 Polyclonal Antibody |
E040846 |
EnoGene |
100μg/100μl |
EUR 255 |
Description: Available in various conjugation types. |
DNAM-1 Polyclonal Antibody |
E041787 |
EnoGene |
100μg/100μl |
EUR 255 |
Description: Available in various conjugation types. |
DNAM-1 Polyclonal Antibody |
E20-75402 |
EnoGene |
100ug |
EUR 225 |
Description: Available in various conjugation types. |
DNAM-1 Polyclonal Antibody |
E20-71381 |
EnoGene |
100ug |
EUR 225 |
Description: Available in various conjugation types. |
DNAM-1 Polyclonal Antibody |
E44H06844 |
EnoGene |
100ul |
EUR 255 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
DNAM-1 Polyclonal Antibody |
E44H01772 |
EnoGene |
100ul |
EUR 255 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
DNAM-1 Polyclonal Antibody |
BT-AP02671-100ul |
Jiaxing Korain Biotech Ltd (BT Labs) |
100ul |
Ask for price |
|
Description: CD226 encodes a glycoprotein expressed on the surface of NK cells, platelets, monocytes and a subset of T cells. It is a member of the Ig-superfamily containing 2 Ig-like domains of the V-set. The protein mediates cellular adhesion of platelets and megakaryocytic cells to vascular endothelial cells. The protein also plays a role in megakaryocytic cell maturation. Alternative splicing results in multiple transcript variants. |
DNAM-1 Polyclonal Antibody |
BT-AP02671-20ul |
Jiaxing Korain Biotech Ltd (BT Labs) |
20ul |
Ask for price |
|
Description: CD226 encodes a glycoprotein expressed on the surface of NK cells, platelets, monocytes and a subset of T cells. It is a member of the Ig-superfamily containing 2 Ig-like domains of the V-set. The protein mediates cellular adhesion of platelets and megakaryocytic cells to vascular endothelial cells. The protein also plays a role in megakaryocytic cell maturation. Alternative splicing results in multiple transcript variants. |
DNAM-1 Polyclonal Antibody |
BT-AP02671-50ul |
Jiaxing Korain Biotech Ltd (BT Labs) |
50ul |
Ask for price |
|
Description: CD226 encodes a glycoprotein expressed on the surface of NK cells, platelets, monocytes and a subset of T cells. It is a member of the Ig-superfamily containing 2 Ig-like domains of the V-set. The protein mediates cellular adhesion of platelets and megakaryocytic cells to vascular endothelial cells. The protein also plays a role in megakaryocytic cell maturation. Alternative splicing results in multiple transcript variants. |
DNAM-1 Polyclonal Antibody |
BT-AP02672-100ul |
Jiaxing Korain Biotech Ltd (BT Labs) |
100ul |
Ask for price |
|
Description: CD226 encodes a glycoprotein expressed on the surface of NK cells, platelets, monocytes and a subset of T cells. It is a member of the Ig-superfamily containing 2 Ig-like domains of the V-set. The CD226 molecule mediates cellular adhesion of platelets and megakaryocytic cells to vascular endothelial cells. The protein also plays a role in megakaryocytic cell maturation. Alternative splicing results in multiple transcript variants. |
DNAM-1 Polyclonal Antibody |
BT-AP02672-20ul |
Jiaxing Korain Biotech Ltd (BT Labs) |
20ul |
Ask for price |
|
Description: CD226 encodes a glycoprotein expressed on the surface of NK cells, platelets, monocytes and a subset of T cells. It is a member of the Ig-superfamily containing 2 Ig-like domains of the V-set. The CD226 molecule mediates cellular adhesion of platelets and megakaryocytic cells to vascular endothelial cells. The protein also plays a role in megakaryocytic cell maturation. Alternative splicing results in multiple transcript variants. |
DNAM-1 Polyclonal Antibody |
BT-AP02672-50ul |
Jiaxing Korain Biotech Ltd (BT Labs) |
50ul |
Ask for price |
|
Description: CD226 encodes a glycoprotein expressed on the surface of NK cells, platelets, monocytes and a subset of T cells. It is a member of the Ig-superfamily containing 2 Ig-like domains of the V-set. The CD226 molecule mediates cellular adhesion of platelets and megakaryocytic cells to vascular endothelial cells. The protein also plays a role in megakaryocytic cell maturation. Alternative splicing results in multiple transcript variants. |
DNAM-1 Polyclonal Antibody |
MBS9243428-01mL |
MyBiosource |
0.1mL |
EUR 415 |
DNAM-1 Polyclonal Antibody |
MBS9243428-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1841 |
DNAM-1 Polyclonal Antibody |
MBS9246018-01mL |
MyBiosource |
0.1mL |
EUR 415 |
DNAM-1 Polyclonal Antibody |
MBS9246018-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1841 |
DNAM-1 Polyclonal Antibody |
MBS9414684-005mL |
MyBiosource |
0.05mL |
EUR 245 |
DNAM-1 Polyclonal Antibody |
MBS9414684-01mL |
MyBiosource |
0.1mL |
EUR 305 |
DNAM-1 Polyclonal Antibody |
MBS9414684-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1230 |
DNAM-1 Polyclonal Antibody |
MBS9405445-005mL |
MyBiosource |
0.05mL |
EUR 245 |
DNAM-1 Polyclonal Antibody |
MBS9405445-01mL |
MyBiosource |
0.1mL |
EUR 305 |
DNAM-1 Polyclonal Antibody |
MBS9405445-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1230 |
DNAM-1 Polyclonal Antibody |
MBS8522362-01mg |
MyBiosource |
0.1mg |
EUR 305 |
DNAM-1 Polyclonal Antibody |
MBS8522362-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 465 |
DNAM-1 Polyclonal Antibody |
MBS8522362-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 465 |
DNAM-1 Polyclonal Antibody |
MBS8522362-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 465 |
DNAM-1 Polyclonal Antibody |
MBS8522362-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 465 |
DNAM-1 Polyclonal Antibody |
MBS8526383-01mg |
MyBiosource |
0.1mg |
EUR 305 |
DNAM-1 Polyclonal Antibody |
MBS8526383-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 465 |
DNAM-1 Polyclonal Antibody |
MBS8526383-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 465 |
DNAM-1 Polyclonal Antibody |
MBS8526383-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 465 |
DNAM-1 Polyclonal Antibody |
MBS8526383-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 465 |
DNAM-1 Polyclonal Antibody |
MBS2534678-002mL |
MyBiosource |
0.02mL |
EUR 140 |
DNAM-1 Polyclonal Antibody |
MBS2534678-006mL |
MyBiosource |
0.06mL |
EUR 180 |
DNAM-1 Polyclonal Antibody |
MBS2534678-012mL |
MyBiosource |
0.12mL |
EUR 260 |
DNAM-1 Polyclonal Antibody |
MBS2534678-02mL |
MyBiosource |
0.2mL |
EUR 405 |
DNAM-1 Polyclonal Antibody |
MBS2534715-002mL |
MyBiosource |
0.02mL |
EUR 140 |
The purpose of this research is to systematically summarize the accuracy of KRAS mutation measurement in colorectal most cancers using cell-free DNA in liquid biopsy samples, with tumor tissue pattern as reference (gold customary). We will search literatures within the following databases: Pubmed, Embase, and Cochrane Library. Systemic assessment and meta-analysis can be carried out to summarize the accuracy of KRAS mutation measurement in colorectal most cancers using liquid biopsy pattern, and subgroup evaluation can be carried out on totally different testing platforms, and on metastatic and non-metastatic colorectal most cancers.